South America Plasma Fractionation Market to Grow at a CAGR of 4.5% to reach US$ 2,663.87 million from 2021 to 2028

The plasma fractionation market in SAM is expected to grow from US$ 1,955.98 million in 2021 to US$ 2,663.87 million by 2028; it is estimated to grow at a CAGR of 4.5% from 2021 to 2028.

Brazil and Argentina are major economies in SAM. The market players associated with metabolomics are actively exploring the possible innovative technologies to facilitate researchers and medical care as the plasma containing the essential components to treat a disease, such as antibodies. Various studies are being carried out on the possible applications of plasma for illnesses that are difficult to cure by employing traditional approaches. Moreover, rising awareness about the advantages of blood donation and applications of plasma among people is expected to open new scope for the market. Hence, various novel diseases getting treated with the use of plasma therapy is the major factor driving the growth of the SAM plasma fractionation market.

There has been an increase in the number of cases in SAM countries since the outbreak of COVID-19's second wave. According to the International Council of Nurses, due to high virus transmission, the number of mortalities among health professionals in Brazil is higher than in other nations. Currently, the countries in SAM are speedily increasing their clinical programs to fight against COVID-19. In this scenario, the pharmaceutical and biopharmaceutical companies are emphasizing on developing novel treatment therapies for the treatment of COVID-19, which is negatively impacting the market. Furthermore, due to the lockdowns imposed in several countries of SAM, the supply of blood and related products also diminished as people could not step outside their homes to donate. As the supply of blood diminished, it adversely affected plasma processing companies. Thus, the COVID-19 outbreak is likely to have a negative impact on market growth.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the SAM plasma fractionation market. The SAM plasma fractionation market is expected to grow at a good CAGR during the forecast period.

SAM Plasma FractionationMarket Revenue and Forecast to 2028 (US$ Million)

SAM Plasma Fractionation Market Segmentation

SAM Plasma Fractionation Market – By Product

• Immunoglobulin
  • Intravenous Immunoglobulin (IVIG)
  • Subcutaneous Immunoglobulin (SCIG)
• Albumin
• Coagulation Factor Concentrates
• Protease Inhibitors
• Other

SAM Plasma Fractionation Market – By Application

• Neurology
• Immunology
• Hematology
• Critical Care
• Pulmonology
• Others

SAM Plasma Fractionation Market – By End User

• Hospitals and Clinics
• Clinical Research Laboratories
• Academic Institutes

SAM Plasma Fractionation Market, by Country

• Brazil
• Argentina
• Rest of SAM

SAM Plasma Fractionation Market - Companies Mentioned

• Bharat Serums and Vaccines Limited (BSV)
• Bio Products Laboratory Ltd.
• Biotest AG.
• CSL Limited
• Grifols, S.A.
• Kedrion S.p.A
• Octapharma AG
• SK Plasma

South America Plasma Fractionation Report Scope